(Q44035146)

English

The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dy (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Asim Orem

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Y Emre Yandi

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Birgül Vanizor

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Gülseren Cimşit

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hüseyin Avni Uydu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Meltem Malkoç

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Clinical Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

217-224

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Polymorphonuclear leukocyte elastase levels in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Free radicals in disease processes: a compilation of cause and consequence

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Lipoprotein cholesterol concentrations in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Relationship between lipid peroxidation and disease activity in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Atherosclerosis and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

A new sensitive assay for the measurement of hydroperoxides

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Catalase in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Carnitine and antioxidants levels in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Distribution of serum lipoprotein (a) concentrations in a healthy Turkish population

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Clinical significance of antibodies against oxidised low density lipoprotein in early RA.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Lipid peroxidation--a common pathogenetic mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Role of endothelium in thrombosis and hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Soluble adhesion molecules in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900290-4

7 January 2021

Identifiers

10.1016/S0009-9120(02)00290-4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44035146&oldid=2105819412"